Cargando…
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
Autores principales: | Roncon, Loris, Zuin, Marco, Rigatelli, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201114/ https://www.ncbi.nlm.nih.gov/pubmed/32378044 http://dx.doi.org/10.1007/s11739-020-02358-4 |
Ejemplares similares
-
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Allione, Attilio, et al.
Publicado: (2020) -
Age-adjusted d-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021) -
Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021) -
Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism!
por: Zuin, Marco, et al.
Publicado: (2021) -
Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)